Press release

Business Wire6 February 2026

Affirm and Virgin Media O2 partner to bring flexible financing to O2 customers
Read More »
Cision PR Newswire6 February 2026

Wanxiang A123 Ends the Era of Thermal Runaway with Semi-Solid-State and Immersion Cooling Technologies
Read More »
Press Release

Cision PR Newswire6 February 2026

TCL Elevates Olympic Winter Games for Fans and Athletes at Milano Cortina 2026, Empowering Audiences Worldwide with Vision of “It’s Your Greatness”
Read More »
Press Release

Cision PR Newswire6 February 2026

AISpeech’s AI‑Powered Matrix Microphone Wins ISE2026 Best of Show Award for Revolutionary Debut
Read More »
Press Release

Cision PR Newswire6 February 2026

PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
Read More »
Cision PR Newswire6 February 2026

Images over two decades: From Yixian to the world
Read More »
Business Wire6 February 2026

Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 49th Annual Midwinter Meeting
Read More »
Cision PR Newswire6 February 2026

CGTN: Xi Jinping’s same-day calls with Putin and Trump underscore China’s role in global stability
Read More »
Business Wire6 February 2026

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit – Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Read More »
Business Wire6 February 2026

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law Firm
Read More »

Previous page Next page